Drug compound could be next-generation treatment for aggressive form of leukemia
About 19,520 news cases are diagnosed a year, and about 10,670 people a year die from acute myeloid leukemia, according to the American Cancer Society.
Purdue University researchers are developing a series of drug compounds that have shown promise in treating such cases.